ImmunoGen
IMGN
$31.23
Share price
0.00%
Change (1 day)
636.56%
Change (1 year)
Categories
ImmunoGen (IMGN) - Cash on Hand
Cash on Hand as of September 2023 : $0.60 B
According to ImmunoGen
's latest financial reports the company has $0.60 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
ImmunoGen - Cash on Hand chart (from 2001 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.27 B | -42.53% |
| 2021-12-31 | $0.47 B | 62.92% |
| 2020-12-31 | $0.29 B | 66.75% |
| 2019-12-31 | $0.17 B | -32.8% |
| 2018-12-31 | $0.26 B | -1.82% |
| 2017-12-31 | $0.26 B | |
| 2016-06-30 | $0.24 B | -11.9% |
| 2015-06-30 | $0.27 B | 95.49% |
| 2014-06-30 | $0.14 B | -27.03% |
| 2013-06-30 | $0.19 B | 21.14% |
| 2012-06-30 | $0.16 B | -15.83% |
| 2011-06-30 | $0.19 B | 73.35% |
| 2010-06-30 | $0.11 B | 55.08% |
| 2009-06-30 | $71.12 M | 48.58% |
| 2008-06-30 | $47.87 M | -19.81% |
| 2007-06-30 | $59.7 M | -20.42% |
| 2006-06-30 | $75.02 M | -17.16% |
| 2005-06-30 | $90.56 M | -4.28% |
| 2004-06-30 | $94.61 M | -6.58% |
| 2003-06-30 | $0.10 B | -26.53% |
| 2002-06-30 | $0.13 B | 45.87% |
| 2001-06-30 | $94.49 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 3,686.24% | 🇺🇸 USA |
 Novartis NVS | $13.96 B | 2,205.73% | 🇨🇭 Switzerland |
 Pfizer PFE | $12.69 B | 1,995.67% | 🇺🇸 USA |
 Eli Lilly LLY | $2.92 B | 383.49% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | 1,707.33% | 🇺🇸 USA |
 Sanofi SNY | $9.92 B | 1,539.57% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $12.28 B | 1,927.96% | 🇺🇸 USA |
 Seagen
SGEN | $1.23 B | 104.28% | 🇺🇸 USA |